Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

v3.24.1.u1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Revenue $ 3,756 $ 4,122
Cost of revenue 1,805 2,122
Gross profit 1,951 2,000
Operating expenses:    
Sales and marketing 1,818 2,088
Research and development 1,136 1,154
General and administrative 2,253 3,206
Total operating expenses 5,207 6,448
Loss from operations (3,256) (4,448)
Other (expense) income, net:    
Interest expense, net (57) (112)
Loss on modification of warrant (109) 0
Gain (loss) on revaluation of warrant liabilities 342 (26)
Unrealized (loss) gain on foreign exchange (349) 217
Other income (expense), net 0 (20)
Total other (expense) income, net (173) 59
Net loss (3,429) (4,389)
Other comprehensive income (loss) 291 (194)
Comprehensive loss $ (3,138) $ (4,583)
Net loss per share applicable to common shareholders, basic and diluted (in dollars per share) $ (0.2) $ (0.33)
Weighted average number of shares outstanding, basic and diluted (in shares) 17,419 13,296